Ozdemir B Handan, Aksoy Pinar Kaynak, Haberal A Nihan, Demirhan Beyhan, Haberal Mehmet
Faculty of Medicine, Başkent University, Ankara, Turkey.
Ren Fail. 2004 May;26(3):247-51. doi: 10.1081/jdi-200026752.
Research on renal biopsies has shown that HLA class I antigens are distributed throughout the renal parenchyma, but that the distribution of HLA-DR varies greatly. We investigated HLA-DR expression in biopsies of 90 renal transplants, and also semiquantitatively assessed the proportions of CD68-, CD3-, and HLA-DR-positive infiltrating cells by immunohistochemistry. The relationships between tubular DR expression and interstitial lymphocyte and macrophage infiltration were examined. Forty of the biopsies showed acute rejection (AR), 33 showed chronic rejection (CR), 10 showed suspected rejection (SR), and 7 showed no evidence of rejection (NR). HLA-DR expression was noted in 35/40 (87.5%) of the AR cases, 22/33 (66.6%) of the CR cases, and 6/10 (60%) of the SR cases. Only 1 (14.3%) of the NR cases exhibited HLA-DR antigen expression in the renal tubules. The proportions of lymphocyte and macrophage infiltration observed in the interstitium were significantly correlated with tubular DR expression in all cases (p<0.01). At 6 months after biopsy was done, 24/35 (68.6%) of the AR patients with tubular DR expression had showed second episode of rejection or showed deteriorated renal function. The remaining 11 AR cases with tubular DR expression had stable renal function at this stage. The cases that had no significant tubular DR expression had no problems with rejection or functional deterioration. These findings are consistent with the theory that expression of HLA-DR antigens on renal tubular cells may be a marker of rejection and poor graft outcome.
对肾活检的研究表明,HLA I类抗原分布于整个肾实质,但HLA - DR的分布差异很大。我们调查了90例肾移植活检组织中HLA - DR的表达情况,并通过免疫组化半定量评估了CD68、CD3和HLA - DR阳性浸润细胞的比例。研究了肾小管DR表达与间质淋巴细胞和巨噬细胞浸润之间的关系。40例活检显示急性排斥反应(AR),33例显示慢性排斥反应(CR),10例显示疑似排斥反应(SR),7例未发现排斥反应迹象(NR)。HLA - DR表达在40例AR病例中的35例(87.5%)、33例CR病例中的22例(66.6%)以及10例SR病例中的6例(60%)被观察到。仅1例(14.3%)NR病例在肾小管中表现出HLA - DR抗原表达。在所有病例中,间质中观察到的淋巴细胞和巨噬细胞浸润比例与肾小管DR表达显著相关(p<0.01)。活检后6个月,35例肾小管有DR表达的AR患者中有24例(68.6%)出现第二次排斥反应或肾功能恶化。其余11例有肾小管DR表达的AR病例在此阶段肾功能稳定。肾小管无明显DR表达的病例未出现排斥反应或功能恶化问题。这些发现与肾小管细胞上HLA - DR抗原的表达可能是排斥反应和移植预后不良的标志物这一理论相一致。